Close

pagibaximab (TAB-H53)

DESCRIPTION CATALOG # SIZE PRICE
Anti-S. epidermidis LTA Therapeutic Antibody TAB-H53 1mg Please Inquiry

PRODUCT INFORMATION

  • Product Overview
  • Recombinant Chimeric (human/mouse) antibody to S. epidermidis LTA. Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight.
  • Type
  • IgG1 - kappa
  • Species Reactivity
  • S. epidermidis
  • Expression Host
  • CHO
  • Applications
  • Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, WB and most other immunological methods.
  • CAS
  • 595566-61-3
  • Specificity
  • Staphylococcus epidermidis lipoteichoic acid [Staphylococcus epidermidis]
  • Protein Construction
  • immunoglobulin G1, anti-(Staphylococcus epidermidis lipoteichoic acid)(human-mouse monoclonal heavy chain), disulfide with human- mousemonoclonal κ-chain, dimer
  • Purity
  • >95.0% as determined by Analysis by RP-HPLC & analysis by SDS-PAGE.

BACKGROUND

  • Introduction
  • Lipoteichoic acid (LTA) is a major constituent of the cell wall of Gram-positive bacteria. These organisms have an inner (or cytoplasmic) membrane and, external to it, a thick (up to 80 nanometer) peptidoglycan layer. The structure of LTA varies between the different species of Gram positive bacteria and may contain long chains of ribitol or glycerol phosphate.
  • Keywords
  • Lipoteichoic acid; LTA; S. epidermidis LTA; Staphylococcus epidermidis lipoteichoic acid

Related Products

Online Inquiry

Verification code
Click image to refresh the verification code.

CONTACT US

45-1 Ramsey Road, Shirley, NY 11967, USA
Call us at:
USA: 1-631-381-2994
Europe: 44-207-097-1828
Fax: 1-631-207-8356
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us